Home › NDC Lookup › RxCUI directory › RxCUI 1190568

Atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution — RxCUI 1190568

Name: Atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution (RxCUI 1190568)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1190568 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1190568

Official nameAtropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asatropine sulfate 0.025 MG / diphenoxylate HCl 2.5 MG per 5 ML Oral Solution; atropine sulfate 0.025 MG / diphenoxylate HCl 2.5 MG in 5 mL Oral Solution

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atropine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That's completely expected with atropine — it's actually doing its job. The drop temporarily shuts down the muscle that controls your pupil and your eye's ability to focus, and tho...
Why does my vision stay blurry and my eyes stay sensitive to light for so long after using these drops?
Good question! When one eye is significantly stronger than the other, the brain tends to ignore the weaker eye. Putting an atropine drop in the stronger eye blurs it on purpose, so...
My child's doctor prescribed these drops for lazy eye — how does that work?

📖 Read our full Atropine Ophthalmic guide →

🕸️ Concept Web — How Atropine sulfate 0.005 MG/ML / diphenoxylate hyd... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Atropine sulfate 0.005 MG/ML / diphenoxylate hydrochloride 0.5 MG/ML Oral Solution RxCUI 1190568 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Atropine 1223 IN
- Diphenoxylate 3500 IN
- Atropine / diphenoxylate 594040 MIN
- Atropine sulfate 153971 PIN
- Diphenoxylate hydrochloride 82005 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Atropine / diphenoxylate Oral Solution 371909 SCDF
- Atropine sulfate / diphenoxylate hydrochloride Oral Solution 2647348 SCDFP
- Atropine / diphenoxylate Oral Liquid Product 1154667 SCDG
- Atropine / diphenoxylate Oral Product 1154668 SCDG
- Atropine sulfate / diphenoxylate hydrochloride Oral Liquid Product 2661757 SCDGP
- Atropine sulfate / diphenoxylate hydrochloride Oral Product 2662971 SCDGP
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Atropine sulfate 0.005 MG/ML 1190566 SCDC
- Diphenoxylate hydrochloride 0.5 MG/ML 1190567 SCDC

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Atropine sulfate 0.005 MG/ML SCDC · 1190566
Diphenoxylate hydrochloride 0.5 MG/ML SCDC · 1190567
Atropine / diphenoxylate Oral Solution SCDF · 371909
Atropine sulfate / diphenoxylate hydrochloride Oral Solution SCDFP · 2647348
Atropine / diphenoxylate Oral Liquid Product SCDG · 1154667
Atropine / diphenoxylate Oral Product SCDG · 1154668
Atropine sulfate / diphenoxylate hydrochloride Oral Liquid Product SCDGP · 2661757
Atropine sulfate / diphenoxylate hydrochloride Oral Product SCDGP · 2662971

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1190568 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00054-3194-46	1 BOTTLE in 1 CARTON (0054-3194-46) / 60 mL in 1 BOTTLE	Diphenoxylate Hydrochloride and Atropine Sulfate	Hikma Pharmaceuticals USA Inc.	1982-05-03

Observed labelers: Hikma Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.